| Literature DB >> 30717102 |
Laura Grauso1, Afsaneh Yegdaneh2, Mohsen Sharifi3, Alfonso Mangoni4, Behzad Zolfaghari5, Virginia Lanzotti6.
Abstract
The saponin composition of a specimen of black sea cucumber, Holothuria atra collected in the Persian Gulf was studied by a combined approach including LC-MS/MS, Molecular Networking, pure compound isolation, and NMR spectroscopy. The saponin composition of Holothuria atra turned out to be more complex than previously reported. The most abundant saponins in the extract (1⁻4) were isolated and characterized by 1D- and 2D-NMR experiments. Compound 1 was identified as a new triterpene glycoside saponin, holothurin A5. The side chain of the new saponin 1, unprecedented among triterpene glycosides, is characterized by an electrophilic enone function, which can undergo slow water or methanol addition under neutral conditions. The cytotoxic activity of compounds 1⁻4, evaluated on the human cervix carcinoma HeLa cell line, was remarkable, with IC50 values ranging from 1.2 to 2.5 µg/mL.Entities:
Keywords: LC-MS/MS; cytotoxic activity; holothurians; molecular networking; saponins; sea cucumbers; triterpene glycosides
Mesh:
Substances:
Year: 2019 PMID: 30717102 PMCID: PMC6410324 DOI: 10.3390/md17020086
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Major holothurins from black sea cucumber Holothuria atra collected in Persian Gulf.
Figure 2MS/MS-based molecular network of the BuOH extract of H. atra. Each node is labeled with the parent mass. Node size is relative to ion count, edge thickness is relative to cosine score. Nodes with the same parent mass refer to isomeric compounds. They were automatically recognized by the MS-Cluster module of GNPS based on their different MS/MS spectra.
Putative identification of saponins present in the molecular network. MS/MS spectra of all compounds are reported in Figures S8–S21 (Supplementary Materials).
| Measured | Retention Time (min) | Molecular Formula | Putative Identification |
|---|---|---|---|
| 859.38 | 23.8 | C41H63O17S− | holothurin B |
| 1165.51 | 23.1 | C54H85O25S− | unknown |
| 1167.53 | 23.6 | C54H87O25S− | unknown |
| 1181.51 | 23.2 | C54H85O26S− | 24-dehydroechinoside A ( |
| 1183.52 | 23.7 | C54H87O26S− | echinoside A ( |
| 1195.48 | 21.5 | C54H83O27S− | calcigeroside B |
| 1197.50 | 21.8 | C54H85O27S− | holothurin A ( |
| 1211.48 | 19.6 | C54H83O28S− | unknown before this study ( |
| 1213.50 | 18.3 | C54H85O28S− | holothurin D |
| 1225.50 | 21.2 | C55H85O28S− | unknown |
| 1229.49 | 17.6, 18.1 | C54H85O29S− | unknown before this study ( |
| 1243.51 | 19.5, 19.7 | C55H87O29S− | unknown before this study ( |
NMR Data of holothurin A5 (1) (1H 700 MHz, 13C 175 MHz, CD3OD).
| Position | δC, Type | δH (Mult, | Sugar | Position | δC, Type | δH (Mult, |
|---|---|---|---|---|---|---|
| 1 | 37.2 (CH2) | 1.51 (m), 1.85 (m) | Xyl | 1′ | 105.5 (CH) | 4.43 (d, 7.5) |
| 2 | 27.4 (CH2) | 1.79 (m), 1.97 (m) | 2′ | 82.2 (CH) | 3.56 (dd, 8.9, 7.5) | |
| 3 | 90.0 (CH) | 3.13 (br. d, 12.0) | 3′ | 75.5 (CH) | 3.73 (t, 8.9) | |
| 4 | 40.9 (C) | 4′ | 77.1 (CH) | 4.22 (m) | ||
| 5 | 53.5 (CH) | 0.98 (d, 12.4) | 5′ | 64.0 (CH2) | 3.37 (t, 10.1), 4.20 (m) | |
| 6 | 21.8 (CH2) | 1.57 (m), 1.76 (m) | ||||
| 7 | 28.8 (CH2) | 1.46 (m), 1.77 (m) | Qui | 1′′ | 104.9 (CH) | 4.61 (d, 7.6) |
| 8 | 41.6 (CH) | 3.02 (dd, 4.0, 13.2) | 2′′ | 76.2 (CH) | 3.29 (dd, 9.0, 7.6) | |
| 9 | 156.2 (C) | 3′′ | 75.6 (CH) | 3.47 (t, 9.0) | ||
| 10 | 40.7 (C) | 4′′ | 86.5 (CH) | 3.17 (t, 9.0) | ||
| 11 | 115.2 (CH) | 5.39 (br. d, 5.7) | 5′′ | 72.2 (CH) | 3.46 (m) | |
| 12 | 71.6 (CH) | 4.55 (br. d, 5.7) | 6′′ | 17.8 (CH3) | 1.36 (d, 6.1) | |
| 13 | 60.0 (C) | |||||
| 14 | 47.3 (C) | Glc | 1′′′ | 104.4 (CH) | 4.42 (d, 7.9) | |
| 15 | 37.2 (CH2) | 1.21 (m), 1.79 (m) | 2′′′ | 74.2 (CH) | 3.41 (m) | |
| 16 | 39.2 (CH2) | 1.90 (m), 2.16 (m) | 3′′′ | 87.2 (CH) | 3.57 (t, 8.9) | |
| 17 | 88.5 (C) | 4′′′ | 69.5 (CH) | 3.41 (m) | ||
| 18 | 175.0 (C) | 5′′′ | 77.4 (CH) | 3.39 (m) | ||
| 19 | 22.6 (CH3) | 1.16 (s) | 6′′′ | 62.3 (CH2) | 3.67 (dd, 11.9, 5.7), 3.89 (dd, 11.9, 2.1) | |
| 20 | 93.0 (C) | |||||
| 21 | 21.1 (CH3) | 1.67 (s) | OMeGlc | 1′′′′ | 104.9 (CH) | 4.58 (d, 7.3) |
| 22 | 198.3 (C) | 2′′′′ | 75.1 (CH) | 3.32 (m) | ||
| 23 | 121.3 (CH) | 6.85 (d, 15.9) | 3′′′′ | 87.3 (CH) | 3.11 (t, 8.7) | |
| 24 | 157.6 (CH) | 7.14 (d, 15.9) | 4′′′′ | 70.8 (CH) | 3.33 (m) | |
| 25 | 71.9 (C) | 5′′′′ | 77.8 (CH) | 3.33 (m) | ||
| 26 | 28.8 (CH3) | 1.34 (s) | 6′′′′ | 62.5 (CH2) | 3.64 (dd, 11.7, 5.7), 3.86 (dd, 11.7, 1.7) | |
| 27 | 28.8 (CH3) | 1.34 (s) | OMe | 60.8 (CH3) | 3.63 (s) | |
| 30 | 16.9 (CH3) | 0.92 (s) | ||||
| 31 | 28.3 (CH3) | 1.09 (s) | ||||
| 32 | 19.8 (CH3) | 1.29 (s) |
Figure 3Diagnostic HMBC correlations for the oligosaccharide chain (green arrows), the holostane nucleus (blue arrows), and the side chain (red arrows) of compound 1.
Figure 4(a) Scheme of the solvolysis reaction occurring between the α,β-unsaturated ketone in the side chain of holothurin A5 (1) and a solution of MeOH/H2O (1:1); (b) LC-MS analysis of compound 1 after having left the compound in a solution of MeOH/H2O (1:1). Two isomeric saponins at 1229.5 (addition of H2O) and two isomeric saponins at 1243.5 (addition of MeOH) appeared in the spectrum; (c) LC-MS analysis of compound 1 left in the same solution of MeOH/H2O (1:1) repeated after 16 weeks. The peaks of the additional saponins showed an increasing intensity.
NMR chemical shifts of the side chain of the two epimers of compounds 5 and 6 (1H 700 MHz, 13C 175 MHz, CD3OD).
| Position | Proton Count | Compound 5 | Compound 6 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5a | 5b | 6a | 6b | ||||||
| δC | δH | δC | δH | δC | δH | δC | δH | ||
| 17 | C | 88.1 | - | 88.4 | - | 88.1 | 88.4 | ||
| 18 | C | 175.0 | - | 175.0 | - | 175.0 | 175.0 | ||
| 19 | CH3 | 22.6 | 1.16 | 22.6 | 1.16 | 22.6 | 1.16 | 22.6 | 1.16 |
| 20 | C | 93.0 | 93.0 | 92.6 | 93.2 | ||||
| 21 | CH3 | 21.1 | 1.674 | 21.1 | 1.667 | 21.1 | 1.672 | 21.1 | 1.669 |
| 22 | C | 209.8 | 209.7 | 209.1 | 209.7 | ||||
| 23 | CH2 | 41.8 | 2.83, 2.86 | 41.8 | 2.83, 2.86 | 41.8 | 2.88, 2.92 | 41.8 | 2.88, 2.92 |
| 24 | CH | 73.9 | 3.95 | 74.2 | 3.95 | 84.4 | 3.64 | 84.0 | 3.64 |
| 25 | C | 73.1 | 73.2 | 73.5 | 73.6 | ||||
| 26 | CH3 | 24.1 | 1.152 | 24.2 | 1.156 | 24.6 | 1.136 | 24.8 | 1.144 |
| 27 | CH3 | 26.8 | 1.218 | 26.7 | 1.208 | 26.8 | 1.220 | 26.7 | 1.210 |
| OMe | 61.3 | 3.46 | 61.3 | 3.46 | |||||
Cytotoxic activity of compounds 1–4 against HeLa cancer cells.
| Compound | IC50 ± SE (µg/mL) a |
|---|---|
| holothurin A5 ( | 1.9 ± 0.1 |
| holothurin A ( | 1.4 ± 0.1 |
| echinoside A ( | 1.2 ± 0.2 |
| 24-dehydroechinoside A ( | 2.5 ± 0.4 |
| adriamycin | 0.6 ± 0.1 |
a Concentration (±standard error) that inhibited 50% of the growth of the HeLa human cervix carcinoma cell-line.
Figure 5A comparison of major triterpene glycosides found in the specimens of Holothuria atra studied so far.